Ole Færgeman
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 28
-
- Lipid metabolism and disorders 14
- Surgery top 0.05%
- Lipoproteins and Cardiovascular Health 106
- Cancer Research top 0.5%
- Cancer, Lipids, and Metabolism 24
- Economics and Econometrics top 0.2%
- Health Systems, Economic Evaluations, Quality of Life 19
-
- Atherosclerosis and Cardiovascular Diseases 13
-
- Cardiac Imaging and Diagnostics 9
-
- RNA Research and Splicing 9
- Co-authors
- Kalevi PyörälàAnders OlssonJohn KjekshusLars WilhelmsenG ThorgeirssonR. Scott WrightKatherine M. BergHD White
- Partner nations
- DenmarkUnited StatesUnited Kingdom
In The Last Decade
Ole Færgeman
188 papers receiving 15.3k citations
Hit Papers
Peers
Comparison fields: 5 of 152
- Endocrinology, Diabetes and Metabolism 5.6k
- Cardiology and Cardiovascular Medicine 5.1k
- Surgery 9.9k
- Cancer Research 2.3k
- Economics and Econometrics 2.8k
Countries citing papers authored by Ole Færgeman
This map shows the geographic impact of Ole Færgeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ole Færgeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ole Færgeman more than expected).
Fields of papers citing papers by Ole Færgeman
This network shows the impact of papers produced by Ole Færgeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ole Færgeman. The network helps show where Ole Færgeman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ole Færgeman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 1 | |
| 2 | 2013 | 1 | |
| 3 | 2011 | 1 | |
| 4 | 2011 | 17 | |
| 5 | 2009 | 44 | |
| 6 | 2008 | 44 | |
| 7 | 2006 | 14 | |
| 8 | Coronary artery disease : genes, drugs, and the agricultural connection | 2003 | 10 |
| 9 | Evidensbaseret medicin, sundhedspolitik og administrativ kontrol med lægers arbejde | 2002 | 2 |
| 10 | 2002 | 2 | |
| 11 | 2001 | 12 | |
| 12 | [Attitude of patients toward detection of hereditary disease. Heterozygote familial hypercholesterolemia]. | 1998 | 1 |
| 13 | 1997 | 63 | |
| 14 | [Significance of food for patients with ischemic heart disease]. | 1996 | 1 |
| 15 | 1996 | 4 | |
| 16 | 1996 | 137 | |
| 17 | 1995 | 118 | |
| 18 | Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)breakdown → | 1994 | 6928 |
| 19 | [Hyperlipidemia in children]. | 1993 | 1 |
| 20 | 1989 | 20 |
About Ole Færgeman
Ole Færgeman is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine, having authored 191 papers that have together received 16.3k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (106 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (28 papers), Cancer, Lipids, and Metabolism (24 papers), Health Systems, Economic Evaluations, Quality of Life (19 papers), Lipid metabolism and disorders (14 papers), Atherosclerosis and Cardiovascular Diseases (13 papers), Cardiac Imaging and Diagnostics (9 papers) and RNA Research and Splicing (9 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (5.6k citations), Cardiology and Cardiovascular Medicine (5.1k citations) and Surgery (9.9k citations). Ole Færgeman has collaborated with scholars based in Denmark, United States and United Kingdom. Frequent co-authors include Kalevi Pyörälà, Anders Olsson, John Kjekshus, Lars Wilhelmsen, G Thorgeirsson, R. Scott Wright, Katherine M. Berg, HD White, Michael Gnant and Christian Spaulding. Their work appears in journals such as Atherosclerosis, Clinical Genetics, Circulation, Human Mutation and The American Journal of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.